The FDA has proposed reclassifying medical image analyzers used in mammography for breast cancer, ultrasound for breast lesions, x-ray for lung nodules and x-ray for dental caries as class II medical devices instead of class III.

Blue Cross Blue Shield of Texas will hold off on implementing its controversial approach to emergency room claims for 60 days after meeting with the state’s insurance commissioner. It was originally set to take effect June 4.

The FDA has proposed reclassifying medical image analyzers used in mammography for breast cancer, ultrasound for breast lesions, x-ray for lung nodules and x-ray for dental caries as class II medical devices instead of class III.

Social media has helped connect teleradiologists from around the world with the few physicians and imaging providers practicing in war-torn Syria, according to a study published May 31 in the Journal of the American College of Radiology.

Avinger announced last week the FDA has approved its next-generation Pantheris Lumivascular atherectomy device, which is used to remove plaque from a blood vessel in those with peripheral artery disease (PAD).

In an era where half of U.S. physicians are, in some way, professionally burned out, medical program directors and administrators are looking for ways to prevent the current generation of medical students from meeting a similar fate—and they’re finding the problem might be rooted in education.

ALISO VIEJO, Calif., May 31, 2018 — MicroVention, Inc., a U.S.-based subsidiary of Terumo and a global neurovascular company, announced today the FDA Premarket Approval (PMA) for the LVIS® and LVIS® Jr. stents for stent-assisted coil embolization of intracranial aneurysms.

Two viewpoint pieces published May 30 in JAMA Cardiology focused on the inequities women face in cardiology, both in terms of compensation and discrimination.

Dual-energy computed tomography (DECT) is growing in popularity as a higher-quality alternative to single-energy CT, but, as a pair of researchers wrote in the current edition of Radiologic Clinics in North America, the method has a long way to go.

Researchers from the UCLA Medical Center found that new FDA-approved volumetric software can help clinicians determine when memory loss is caused by issues other than Alzheimer’s disease, according to research presented at the 2018 American Academy of Neurology (AAN) annual meeting in Los Angeles.